NCT05841966

Brief Summary

Adult patients suspected of Squamous Cell Carcinoma of Unknown Primary (SCCUP) will be prospectively enrolled at a tertiary head \& neck cancer center at Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. All patients will undergo Magnetic Resonance Imaging (MRI) and Positron Emission Tomography-Computerized Tomography (PET-CT) prior to examination in general anesthesia. During general anesthesia, Intraoperative Transoral Ultrasound (ITUS) will be performed prior to panendoscopy. Detected tumors will be registered with specified oropharyngeal sub-locations. Blinded to ITUS, a consultant head \& neck surgeon will perform panendoscopy. After examination, the surgeon is unblinded to ultrasound results. Final histopathology results from location-specified biopsies performed will be used as reference standard. The overall detection rate will be compared between ITUS, panendoscopy, PET-CT and MRI with sensitivity and specificity analysis. Oropharynx sub-location specific detection rate of ITUS vs. panendoscopy will be compared with logistic regression analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 16, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

February 21, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 3, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 29, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

May 7, 2024

Status Verified

May 1, 2024

Enrollment Period

11 months

First QC Date

February 16, 2023

Last Update Submit

May 6, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Increased detection rate by adding ITUS to panendoscopy

    The difference in proportion of patients with SCCUP where a primary tumor location is correctly detected by ITUS but not detected with panendoscopy alone.

    Within 2-4 weeks after panendoscopy.

Secondary Outcomes (2)

  • Ultrasonographic features of primary tonsil and tongue base tumors

    1 year

  • Comparison of detection rate of ITUS, panendoscopy, combined ITUS+panendoscopy, MRI and PET-CT for locating the primary tumor.

    1 year

Other Outcomes (1)

  • Average time in minutes used to perform transoral ultrasound

    1 year

Study Arms (1)

Intraoperative Transoral Ultrasound

EXPERIMENTAL

Transoral ultrasound of the tonsils and tongue base under general anesthesia.

Diagnostic Test: Transoral Ultrasound

Interventions

Transoral UltrasoundDIAGNOSTIC_TEST

The tonsils and tongue base will be scanned transorally using high-frequency intraoperative ultrasound transducers. Direct contact with the tonsils through the mouth is achieved during general anesthesia.

Intraoperative Transoral Ultrasound

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cytology-verified cervical lymph node metastasis from squamous cell carcinoma in neck levels I-IV with HPV+ cytology.
  • Booked for panendoscopic examination under general anesthesia.
  • Pre-operative MRI and PET-CT available.

You may not qualify if:

  • Unable to provide written informed consent.
  • Unable to complete full surgical work-up including palatine- and lingual tonsillectomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Århus University Hospital, Department of Otorhinolaryngology, Head & Neck Surgery

Aarhus, 8200, Denmark

Location

Rigshospitalet, Department of Otorhinolaryngology, Head & Neck Surgery & Audiology

Copenhagen, 2100, Denmark

Location

MeSH Terms

Conditions

Neoplasms, Unknown PrimaryCarcinoma, Squamous Cell

Condition Hierarchy (Ancestors)

Neoplasm MetastasisNeoplastic ProcessesNeoplasmsPathologic ProcessesPathological Conditions, Signs and SymptomsCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasms, Squamous Cell

Study Officials

  • Tobias Todsen, MD, PhD

    Rigshospitalet, Denmark

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 16, 2023

First Posted

May 3, 2023

Study Start

February 21, 2023

Primary Completion

January 29, 2024

Study Completion

March 1, 2024

Last Updated

May 7, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations